Religare Enterprises has released its comprehensive investor presentation for the Q3FY26 earnings call scheduled for February 16, 2026. The company made the presentation available through a regulatory filing dated February 15, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call and Presentation Details

The management has scheduled the earnings call for February 16, 2026, at 04:00 PM IST to discuss operational and financial performance for the quarter and nine months ended December 31, 2025. The investor presentation is now accessible on the company's website and provides detailed insights into all business segments.

Consolidated Financial Performance

The company reported consolidated total income of Rs. 2,067.90 crore for Q3 FY26 compared to Rs. 1,670.20 crore in Q3 FY25. However, the company posted a net loss of Rs. 76.50 crore for Q3 FY26 against a loss of Rs. 63.20 crore in the corresponding quarter of the previous year.

Business Segment Performance

Religare Enterprises operates through multiple business verticals including insurance services through Care Health Insurance, financial services including broking operations through Religare Broking Limited, and lending activities through Religare Finvest Limited and Religare Housing Development Finance Corporation Limited.

Care Health Insurance Performance

Care Health Insurance, India's second-largest standalone health insurer, reported Gross Written Premium of Rs. 2,621 crore in Q3 FY26 compared to Rs. 1,895 crore in Q3 FY25. The company maintains a strong market position with over 22,000 hospital networks and 274 branch offices.

Religare Broking Limited Performance

Religare Broking Limited, operating through 68 branches serving 2.5 lakh active clients, reported total income of Rs. 91.01 crore in Q3 FY26 compared to Rs. 81.47 crore in Q3 FY25. The broking business includes e-governance services and maintains a diversified revenue stream.

Strategic Reorganization Initiative

The company has announced plans for reorganizing its business structure through a proposed demerger of financial services business from Religare Enterprises Limited to Religare Finvest Limited. This reorganization aims to create focused management attention, streamline businesses, and enable separate listing of the financial services business while retaining the insurance business investment in Care Health Insurance.

Regulatory Compliance and Access Information

The announcement was made in compliance with SEBI listing regulations, with Company Secretary Anuj Jain ensuring proper disclosure to both NSE and BSE. The earnings call will accommodate participants from multiple regions with dedicated access numbers for USA, UK, Singapore, and Hong Kong, along with primary Indian numbers.

Religare Enterprises Limited announced its unaudited financial results for Q3 FY26 ended December 31, 2025, with the Board of Directors approving the results during their meeting held on February 14, 2026. The meeting commenced at 12:05 P.M. and concluded at 01:42 P.M.

Standalone Financial Performance

The company reported challenging standalone financial results for the quarter, reflecting operational difficulties across key metrics.

Consolidated Financial Results

The consolidated results showed significantly higher revenue but substantial losses, primarily driven by insurance operations.

Capital Structure Updates

During Q3 FY26, the company made significant equity share allotments that impacted its capital structure:

ESOP Allotments:

• Allotted 1,01,000 equity shares under "Religare Enterprises Limited Employees Stock Option Plan 2019"
• Exercise price ranged from Rs 39.55 per share to Rs 159.25 per share
• Face value of Rs 10 per share

Warrant Conversion:

• Allotted 19,85,816 shares at Rs 235 per share
• Conversion from share warrants during the quarter
• Shares allotted on December 05, 2025

Segment Performance Analysis

The company restructured its segment reporting during the period, bifurcating Investment & Financial Activities into lending, broking, insurance, and other investment activities.

Regulatory and Operational Updates

The company continues to operate under certain regulatory constraints:

Dividend Restrictions:

• Company remains barred from declaring dividends as per RBI letter issued in December 2019

Governance Review:

• Ongoing governance review of the company and subsidiaries Religare Finvest Limited (RFL) and Religare Housing Development Finance Corporation Limited (RHDFCL)
• External law firm engaged for conducting the review
• Objective to review past operating practices and suggest improvements

Labour Code Impact:

• Government of India notified four Labour Codes effective November 21, 2025
• Incremental impact on gratuity of Rs 27.62 lakh and leave encashment of Rs 12.93 lakh
• Impact charged to profit and loss account for the quarter

Auditor Review and Compliance

The unaudited financial results were subjected to limited review by M/s J C Bhalla & Co., Statutory Auditors of the Company, in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The results demonstrate Religare Enterprises' continued focus on regulatory compliance and corporate governance improvements while managing operational challenges across its diversified business segments.